Change - Announcement of Appointment::Appointment of Paolo Maximo Francisco Borromeo as Alternate Director

Issuer & Securities

Issuer/ Manager
YOMA STRATEGIC HOLDINGS LTD.
Securities
YOMA STRATEGIC HOLDINGS LTD - SG1T74931364 - Z59
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
10-Nov-2022 18:09:11
Status
New
Announcement Sub Title
Appointment of Paolo Maximo Francisco Borromeo as Alternate Director
Announcement Reference
SG221110OTHRAVCF
Submitted By (Co./ Ind. Name)
Melvyn Pun
Designation
Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr. Paolo Maximo Francisco Borromeo as Alternate Director to Mr. Jaime Alfonso Antonio Eder Zobel De Ayala

Additional Details

Date Of Appointment
10/11/2022
Name Of Person
Paolo Maximo Francisco Borromeo
Age
45
Country Of Principal Residence
Philippines
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
Mr. Paolo Maximo Francisco Borromeo ("Mr. Paolo Borromeo") is currently the alternate director to Mr. Cezar Peralta Consing since 2 August 2021 and shall be re-designated as the alternate director of Mr. Jaime Alfonso Antonio Eder Zobel De Ayala ("Mr. Jaime"), a newly appointed Director of the Company.
Whether appointment is executive, and if so, the area of responsibility
Non-Independent Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Alternate Director to Mr. Jaime
Professional qualifications
Masters in Business Administration
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
None
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
Booz & Co.: Principal, 2006 - 2012
Ayala Corporation: Managing Director, 2012 - present
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Not Applicable
Present
Ayala Healthcare Holdings, Inc. - Director, President and Chief Executive Officer
Healthway Philippines, Inc. - Director, President and Chief Executive Officer
HMC, Inc. - Director, Chairman
Mercado General Hospital, Inc. - Director, Chairman
AHCHI Pharma Ventures, Inc. - Director, Chairman, President and Chief Executive Officer
Vigos Ventures, Inc. - Director, Chairman and President
Zodiac Health Ventures, Inc. - Director, Chairman and President
I.E. Medica, Inc. - Director, Chairman
Medethix, Inc. - Director, Chairman
Novelis Solutions, Inc. - Director, Vice Chairman
Erikagen, Inc. - Director, Vice Chairman
Pharm Gen Ventures Corporation - Director, Vice Chairman
Actimed, Inc. - Director, Vice Chairman
AC Ventures Holding Corp. - Director
AC Industrial Technology Holdings, Inc. - Director
Ayala International Holdings Limited - Director
AG Holdings Limited- Director
LiveIt Investments Limited - Director
HealthNow, Inc. - Director
APPPPS Partners, Inc. - Director
AC Logistics Holdings Coroporation - Director
Ayala Group Club, Inc. - Director
Zapfam, Inc. - Director
Global Teleheatlh, Inc. - Director
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Mr. Paolo Borromeo has been appointed as an alternate director to Mr. Cezar Peralta Consing, a director of the Company since 2 August 2021. He has attended courses conducted by the Singapore Institute of Directors to familiarise himself with the roles and responsibilities as a director of a company listed on the Singapore Exchange Securities Trading Limited.